Thanks for this, appreciate it.

First 74 Last

Share
Profile

Follow
chb

1,634 Posts.

225

27/04/23

23:42

Post #: 67491547
Share

Originally posted by ellroy80 ↑

Ok, here we go.

On the EIA approval, the Governor and Mining Secretary are very happy with the project. The notification meetings with stakeholders is expected to be the last required step before approval is granted. It was quickly clarified (to the questioner) that these are notification meetings, and not consultation meetings. The expected timeframe for approval was reported in today's quarterly (this last sentence is my words, not his).

On the offtake/capex funding solution, currently in negotiations with a preferred party. Will include an offtake agreement and a full-funding solution for the 10k expansion. Non-dilutive (Ed: so that report that was released circa early Feb was bogus). Sounds like a big player; I know other posters have suggested a Tier 1, and my thoughts are the same from the meeting. Solution isn't contingent on other milestones being reached. Recent lithium price decrease hasn't altered the terms of the agreement. Is expected to be finalised within the same timeframe as the EIA approval.

Results from the production well drilling program are expected in the coming weeks. Data is currently being analysed in Perth. Exploration drilling is expected to take another couple of months, then 2-3 months for results.

On Tonopah, they are focusing on getting certain approvals in place. Big one is water rights.

On new projects - they are very happy to be in the Rincon at the moment. Expansion will happen through resource increase.

On marketing, have focused on marketing to insto's. Mentioned the names of companies who have produced reports (Macquarie etc).

I was able to briefly speak with Pablo before I left the meeting and thanked him for his hard work. Seems like a nice bloke.

That's about it. The next few months will be VERY interesting if the pieces fall into place. My birthday is in July; it could be a very happy birthday indeed!!

Expand

Thanks for this, appreciate it.

AGY Price at posting: 39.0¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

PL3

Patagonia looks to raise $2.15M for South American exploration and development

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

There are more pages in this discussion • 39 more messages in this thread...

First 74 Last

Add AGY (ASX) to my watchlist

(20min delay)
Last 8.8¢		Change 0.000(0.00%)		Mkt cap ! $128.1M

Open	High	Low	Value	Volume
8.8¢	8.9¢	8.6¢	$36.10K	414.1K

Buyers (Bids)

No.	Vol.	Price($)
2	37936	8.6¢

Sellers (Offers)

Price($)	Vol.	No.
8.8¢	15624	1

View Market Depth

No.	Vol.	Price($)
2	37936	0.086
1	11776	0.085
2	211916	0.084
1	12000	0.083
3	154841	0.082

Price($)	Vol.	No.
0.088	15624	1
0.090	34601	2
0.091	381389	1
0.092	119587	3
0.093	211655	3

Last trade - 16.10pm 09/07/2024 (20 minute delay)

AGY (ASX) Chart

Thanks for this, appreciate it.

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Patagonia looks to raise $2.15M for South American exploration and development

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks for this, appreciate it.

Top Stories

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Patagonia looks to raise $2.15M for South American exploration and development

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News